Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

A.P. Pharma targets resubmission of APF530 NDA in 2012

A.P. Pharma, Inc., a specialty pharmaceutical company, today provided an update on its lead product candidate, APF530, for the prevention of chemotherapy-induced nausea and vomiting (CINV).

25 Apr 2011

Pharmatek purchases spray dryer for drug formulation and manufacturing

Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has added spray drying to its drug formulation and manufacturing capabilities. The company has purchased a Buchi B-290 Mini Spray Dryer for formulation feasibility studies and small-scale clinical manufacture. This technology can be used for both oral and parenteral dosage forms.

25 Apr 2011

Congressman Holt congratulates Vaxinnate for BARDA award to develop next generation of flu vaccines

U.S. Congressman Rush Holt (R-12th) visited the headquarters of VaxInnate Corporation today, where he congratulated the biotechnology company on having received a U.S. government contract to fund development of the next generation of flu vaccines and called for more technology investments to improve the health of all Americans.

22 Apr 2011

Baxa increases recycling initiatives by 22%

In conjunction with Earth Day 2011, Baxa Corporation today announced its continued strides to reduce the environmental impact of business operations – from manufacturing efficiency to packaging design and office processes.

22 Apr 2011

Luitpold temporarily suspends distribution of drug products manufactured at Shirley, New York facility

Luitpold Pharmaceuticals, Inc. today announced that it has temporarily suspended distribution of all of its drug products manufactured at its Shirley, New York facility and marketed by its American Regent, Inc. subsidiary and Animal Health Division.

22 Apr 2011

Merck and Sanofi Pasteur commence Phase III trial of pediatric hexavalent combination vaccine

Merck and Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today the initiation of a Phase III clinical program to evaluate the safety and immunogenicity of an investigational pediatric hexavalent combination vaccine.

21 Apr 2011

Repligen anticipates 30% increase in total revenues for 2011

Repligen Corporation today announced preliminary financial results for fiscal year 2011 which ended March 31, 2011. Total revenue for the year is expected to be $27.3 million compared to $21.0 million in the prior fiscal year, an increase of 30%.

21 Apr 2011

Jennerex and Green Cross report positive phase 2 JX-594 clinical trial for liver cancer

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, today reported positive clinical data from a Phase 2 trial evaluating JX-594 for liver cancer which was conducted in South Korea.

21 Apr 2011

Biogen Idec first quarter revenues increase 9% to $1.2 billion

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its first quarter 2011 results.

21 Apr 2011

Shanghai Pharmaceutical and Pfizer enter MOU to pursue potential business opportunities

Shanghai Pharmaceutical Co. Ltd. and Pfizer Inc. today announced the signing of a memorandum of understanding (MOU) for the companies to jointly pursue potential business opportunities in China.

21 Apr 2011

Stepped up measures to tack rising painkiller abuse

Prescription drug abuse is one of the largest problems in the country say experts and according to White House drug Czar Gil Kerlikowske, the Congress must require special training for doctors and other health care workers before they are allowed to prescribe powerful drugs such as OxyContin.

20 Apr 2011

ARIAD executes three exclusive out-license agreements for ARGENT cell-signaling regulation technology

ARIAD Pharmaceuticals, Inc. today announced execution of three exclusive out-license agreements for separate aspects of its ARGENT™ cell-signaling regulation technology.

20 Apr 2011

Adeona, TG United enter commercial-scale manufacturing agreement for reaZin

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement with TG United, Inc. of Brooksville, Florida, to provide commercial-scale manufacturing capabilities for reaZin. Adeona is developing reaZin, its product candidate for the dietary management of Alzheimer's disease and mild cognitive impairment, as a prescription medical food.

20 Apr 2011

Chembio initiates FDA Modular PMA process for DPP HIV 1/2 Screening Assay

Chembio Diagnostics, Inc., which develops, manufactures, markets and licenses point-of-care diagnostic tests, reported it recently filed the first module of its Pre-Marketing Approval (PMA) application to the United States Food & Drug Administration for its DPP® HIV 1/2 Screening Assay.

19 Apr 2011

Johnson & Johnson reports net sales of $16.2 billion for first quarter 2011

Johnson & Johnson today announced sales of $16.2 billion for the first quarter of 2011, an increase of 3.5% as compared to the first quarter of 2010.

19 Apr 2011

Cumberland acquires Vanderbilt's ifetroban rights

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it has entered into an agreement to acquire the rights to ifetroban, a new Phase II development product.

19 Apr 2011

Manufacturing News and Research

Further Reading

A.P. Pharma targets resubmission of APF530 NDA in 2012

Pharmatek purchases spray dryer for drug formulation and manufacturing

Congressman Holt congratulates Vaxinnate for BARDA award to develop next generation of flu vaccines

Baxa increases recycling initiatives by 22%

Luitpold temporarily suspends distribution of drug products manufactured at Shirley, New York facility

Merck and Sanofi Pasteur commence Phase III trial of pediatric hexavalent combination vaccine

Repligen anticipates 30% increase in total revenues for 2011

Jennerex and Green Cross report positive phase 2 JX-594 clinical trial for liver cancer

Biogen Idec first quarter revenues increase 9% to $1.2 billion

Shanghai Pharmaceutical and Pfizer enter MOU to pursue potential business opportunities

Stepped up measures to tack rising painkiller abuse

ARIAD executes three exclusive out-license agreements for ARGENT cell-signaling regulation technology

Adeona, TG United enter commercial-scale manufacturing agreement for reaZin

Chembio initiates FDA Modular PMA process for DPP HIV 1/2 Screening Assay

Johnson & Johnson reports net sales of $16.2 billion for first quarter 2011

Cumberland acquires Vanderbilt's ifetroban rights

Seattle enters second ADC research collaboration agreement with Genmab

Single antibody injection limits tissue and organ destruction after ischaemic events

Obama to rally support for his deficit-reduction plan

First Edition: April 18, 2011

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy